The Play Framework as an Alternative to Spring - In Person

NOTE: This is the in-person version of this event. Click here for the virtual version.

Title: The Play Framework as an Alternative to Spring

Abstract:
For over a decade, the Play Framework has been used to build highly-scalable web applications using a Model View Controller architecture. Although commonly associated with Scala, Play applications can be built entirely in Java as well. It features a fully stateless, RESTful architecture with an emphasis on asynchronous I/O to prevent blocking operations from tying up your HTTP threads. In addition, Play integrates with many modern relational or non-relational databases through JDBC or ORM frameworks.

We'll be reviewing the various features of the Play Framework and demonstrating how to use its Java API to build a modern implementation of the venerable Java Pet Store application.

Speaker Bio:
Greg Taylor is a Software Engineering Manager at Pinnacle 21. He has been a Java developer for 12 years, working primarily in the Life Sciences sector. He is a co-organizer of Philly JUG and has been a JUG member since 2010. In his spare time, he enjoys auto racing with Philly Sports Car Club of America and rowing.
Sponsored By: Jakarta EE - Open Source Cloud Native Java (https://jakarta.ee)

Powered by participation, Jakarta EE is focused on enabling community-driven collaboration and open innovation for the cloud. Jakarta EE represents the best way to drive cloud-native, mission-critical applications and build upon the decades of experience of real-world deployments and developers.

Location and Sponsor: Pinnacle 21
Employees at Pinnacle 21 do tech work that means something. Their software enables key transitions in the clinical trial data pipeline and streamlines regulatory approvals for drugs and medical devices, getting new treatments to patients faster.

Pinnacle 21 supplies its SaaS platform to the US FDA, Japan’s PMDA, 22 of the top 25 biopharma firms, and many more biotechs. It ensures clinical trial data comply with the standards of both government agencies and trial sponsors.

On its way from the clinic to a government agency, a data point goes through many steps, and Pinnacle 21 has processed over 30 trillion (with a T!) of them. With strong product-market fit and an aggressive roadmap fueled by their 2021 acquisition by Certara (NASDAQ: CERT), the team is quickly becoming the one-stop data brokerage for the life sciences.